Close
Smartlab Europe
Achema middle east

Press Releases

Patheon® to Feature API Development and Manufacturing Capabilities at CPhI/ICSE Worldwide

Patheon is to showcase its biologic, small molecule API development services and manufacturing capabilities for finished dosage forms at CPhI / ICSE Worldwide from Tuesday 7 October to Thursday 9 October in Paris Nord Villepinte, France. ...

Endo International has persuaded Auxilium Pharma into a takeover that leaves an earlier plan to merge Auxilium with QLT in tatters.

Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium - which has been approved by the boards of both companies - that will add the latter's portfolio of testosterone replacement therapies to Endo fast-growing speciality pharma business. ...

Pharming and Swedish Orphan Biovitrum Amend and Extend Ruconest Distribution Agreement

Pharming to Directly Commercialise Ruconest in Austria Germany and NetherlandsBiotech company Pharming Group NV ("Pharming" or "the Company") (EURONEXT: PHARM) and Swedish Orphan Biovitrum AB (publ) or "Sobi" (SS: SOBI) today announced the amendment and extension of the Ruconest®...

Therapure Biopharma to Attend BioProcess International Conference & Exhibition

Therapure Biopharma is appearing at the upcoming BioProcess International Conference & Exhibition. The company can be found at booth number 818. The event takes place from Monday 20 October to Thursday 23 October at Hynes Convention...

Boehringer brings Striverdi Respimat to market for COPD treatment in US

Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market. Striverdi Respimat is indicated to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ...

Pharma ‘cannot deliver patient centricity’

Eyeforpharma, London, September 2014: Mary Baker, immediate past President of the European Brain Council, believes that pharma companies are focusing too much on patient centricity and instead, should widen their focus to include the whole...

Grupo Juste to supply D&A Pharma’s Alcover in Spain and Central America

France-based D&A Pharma has entered into an exclusive supply, licensing and distribution agreement with Grupo Juste for Alcover, sodium oxybate, a treatment for alcohol dependence. As part of the deal, Grupo Juste will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »